8-K BridgeBio Pharma, Inc. 2026-08-31: filed_by
| Value | {"cik": "0001743881", "company": "BridgeBio Pharma, Inc.", "accession": "0001140361-26-035055", "entity_ref": "fb601193-3db4-4480-8b24-035f7324e6a4", "period_of_report": "2026-08-31"} |
|---|---|
| Period | (as of 2026-08-31) |
| Status | current |
| Entity | 8-K BridgeBio Pharma, Inc. 2026-08-31 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1743881/000114036126035055/0001140361-26-035055-in
Retrieved: 2026-08-31T22:09:22.278419+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/484d024c-891f-4c8d-bd2d-13299e53609f
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1743881/000114036126035055/0001140361-26-035055-in
Retrieved: 2026-08-31T22:09:22.278419+02:00
Raw response sha256:
1ccbd93404bbe9c6f3b59864b99e1626…Cite as: FACTANKER, https://factanker.com/fact/484d024c-891f-4c8d-bd2d-13299e53609f
History
- no predecessors — first report